We would like to thank our exhibitors and sponsors for sponsoring this meeting which includes pharmaceutical companies, including Cipla and Tillotts Pharma UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

The first session is a promotional webinar sponsored and organised by Tillotts Pharma UK Ltd for UK Healthcare Professionals Only. Tillotts Pharma UK Ltd products will be discussed during this webinar. The speaker has received an honorarium for this session.

Tuesday, November 11, 2025
7:00 PM - 7:35 PM
Chair's opening remarks followed by: Optimising mesalazine in primary care – the pharmacists’ role in managing mild-moderate ulcerative colitis
  • The session will provide an overview of mild-moderate ulcerative colitis guidelines and treatment, and the importance of community based care for these patients
  • The evidence behind optimising the dose of mesalazine and the importance of adherence will be discussed.
  • Practical tips from a specialist gastroenterology pharmacist on how impactful and meaningful practice and GP pharmacists can be in facilitating positive patient outcomes in mild-moderate UC.
 
This is a promotional webinar sponsored and organised by Tillotts Pharma UK Ltd for UK Healthcare Professionals Only. Tillotts Pharma UK Ltd products will be discussed during this webinar. The speaker has received an honorarium for this session.
Chair's opening remarks followed by: Optimising mesalazine in primary care – the pharmacists’ role in managing mild-moderate ulcerative colitis
 

OCATSA (mesalazine) tablets and suppositories – prescribing information: https://www.tillotts.co.uk/octasa-pi-page/

October 2025 PU-02763

Adverse events should be reported. Reporting forms and information can be found at  https://yellowcard.mhra.gov.uk. Adverse events should also be reported to Tillotts Pharma UK Ltd. (Tillotts Pharma UK Ltd, The Larbourne Suite, The Stables, Wellingore Hall, Wellingore, Lincolnshire, LN5 0HX, UK) Tel: 01522 813500.

7:45 PM - 8:15 PM
It is not just the dose counter that counts
  • The importance of dose counters in an inhaler
  • Key take home messages from NICE/BTS/SIGN guidelines (NG245) for the treatment Asthma
  • Carbon savings and environmental impact 
 
This is a sponsored session by Cipla. Cipla products will be discussed. Attendance at the promotional session by Cipla is optional.
It is not just the dose counter that counts
 
 
8:25 PM - 9:30 PM
Three Quick-Fire Clinical Updates - desprescribing, weight management and women's health

1: Award winning collaboration: Physiotherapist & Pharmacist deprescribing together.

  • Why we need to act
  • A new way of Working
  • How we did it
  • What we achieved
  • Next Steps & Sustaining Change  

2: Weight Management  

  • Safe prescribing of weight management injections
  • Counselling
  • Follow up regular monitoring and treatment support, medication review

3: Women's Health  

  • Use of incretin-based therapies in contraception and HRT
  • Updates on medical management of fibroids  and endometriosis
  • Testosterone review in primary care  

4. Q&A with all three speakers  

 
 
 
 
 

If you are interested in speaking at this event, please contact Lisa Thomlinson, Events Director.

If you are interested in sponsoring a talk on the Agenda, or exhibiting at the event, please contact Ed Burkle, Sales Director.